Literature DB >> 15180329

Correction of permeability with pore radius of tight junctions in Caco-2 monolayers improves the prediction of the dose fraction of hydrophilic drugs absorbed by humans.

Ryoichi Saitoh1, Kiyohiko Sugano, Noriyuki Takata, Tatsuhiko Tachibana, Atsuko Higashida, Yoshiaki Nabuchi, Yoshinori Aso.   

Abstract

PURPOSE: To improve predictions of fraction dose absorbed (Fa) for hydrophilic drugs, a correction of paracellular permeability using the pore radius of tight junctions (TJs) in Caco-2 monolayers was performed.
METHODS: The apparent permeability coefficient (P9app)) of drugs was measured using the Caco-2 assay and the parallel artificial membrane permeation assay (PAMPA), and values were corrected with the pore radius of TJs.
RESULTS: An equation for calculating the pore radius of TJs from the P(app) of lucifer yellow was obtained. The optimal pore radius of TJs in Caco-2 monolayers for predicting human Fa was calculated to be 7 A. The correlation between the actual and predicted Fa was improved by using the P(app) corrected with the pore radius of TJs. Permeability in the PAMPA, which was corrected using the pore radius and membrane potential, was well correlated with that in the Caco-2 assay. Most of the hydrophilic drugs tested in this study were absorbed mainly through the paracellular pathway.
CONCLUSIONS: The results suggest the necessity of optimizing paracellular permeation for the prediction of Fa, and also the importance of the paracellular pathway to the absorption of hydrophilic drugs. This method might contribute to the setting of appropriate dosages and the development of hydrophilic drugs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15180329     DOI: 10.1023/b:pham.0000026423.48583.e2

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  18 in total

1.  A comparative study of artificial membrane permeability assay for high throughput profiling of drug absorption potential.

Authors:  Chengyue Zhu; Lan Jiang; Teng-Man Chen; Kin-Kai Hwang
Journal:  Eur J Med Chem       Date:  2002-05       Impact factor: 6.514

2.  Pharmacokinetic interpretation of blood levels and urinary excretion data for cefazolin and cephalothin after intravenous and intramuscular administration in humans.

Authors:  E S Rattie; L J Ravin
Journal:  Antimicrob Agents Chemother       Date:  1975-05       Impact factor: 5.191

3.  Prediction of passive intestinal absorption using bio-mimetic artificial membrane permeation assay and the paracellular pathway model.

Authors:  Kiyohiko Sugano; Noriyuki Takata; Minoru Machida; Kimitoshi Saitoh; Katsuhide Terada
Journal:  Int J Pharm       Date:  2002-07-25       Impact factor: 5.875

4.  Paracellular diffusion in Caco-2 cell monolayers: effect of perturbation on the transport of hydrophilic compounds that vary in charge and size.

Authors:  G T Knipp; N F Ho; C L Barsuhn; R T Borchardt
Journal:  J Pharm Sci       Date:  1997-10       Impact factor: 3.534

5.  Food intake and dosage level, but not tablet vs solution dosage form, affect the absorption of metformin HCl in man.

Authors:  N C Sambol; L G Brookes; J Chiang; A M Goodman; E T Lin; C Y Liu; L Z Benet
Journal:  Br J Clin Pharmacol       Date:  1996-10       Impact factor: 4.335

6.  Species differences in size discrimination in the paracellular pathway reflected by oral bioavailability of poly(ethylene glycol) and D-peptides.

Authors:  Y L He; S Murby; G Warhurst; L Gifford; D Walker; J Ayrton; R Eastmond; M Rowland
Journal:  J Pharm Sci       Date:  1998-05       Impact factor: 3.534

7.  [Cefazolin. 2. Primary clinical trial by oral administration].

Authors:  K Seiga; M Minakawa; K Miyoshi; K Yamaji; Y Sugiyama
Journal:  Jpn J Antibiot       Date:  1972-02

8.  Passive movement of water and sodium across the human small intestinal mucosa.

Authors:  K H Soergel; G E Whalen; J A Harris
Journal:  J Appl Physiol       Date:  1968-01       Impact factor: 3.531

Review 9.  Strategies for absorption screening in drug discovery and development.

Authors:  H Bohets; P Annaert; G Mannens; L Van Beijsterveldt; K Anciaux; P Verboven; W Meuldermans; K Lavrijsen
Journal:  Curr Top Med Chem       Date:  2001-11       Impact factor: 3.295

10.  Estimating human oral fraction dose absorbed: a correlation using rat intestinal membrane permeability for passive and carrier-mediated compounds.

Authors:  G L Amidon; P J Sinko; D Fleisher
Journal:  Pharm Res       Date:  1988-10       Impact factor: 4.200

View more
  14 in total

Review 1.  Repurposing metformin for the prevention of cancer and cancer recurrence.

Authors:  Brandy M Heckman-Stoddard; Andrea DeCensi; Vikrant V Sahasrabuddhe; Leslie G Ford
Journal:  Diabetologia       Date:  2017-08-03       Impact factor: 10.122

Review 2.  Coexistence of passive and carrier-mediated processes in drug transport.

Authors:  Kiyohiko Sugano; Manfred Kansy; Per Artursson; Alex Avdeef; Stefanie Bendels; Li Di; Gerhard F Ecker; Bernard Faller; Holger Fischer; Grégori Gerebtzoff; Hans Lennernaes; Frank Senner
Journal:  Nat Rev Drug Discov       Date:  2010-08       Impact factor: 84.694

3.  Intestinal absorptive transport of the hydrophilic cation ranitidine: a kinetic modeling approach to elucidate the role of uptake and efflux transporters and paracellular vs. transcellular transport in Caco-2 cells.

Authors:  David L Bourdet; Gary M Pollack; Dhiren R Thakker
Journal:  Pharm Res       Date:  2006-06-08       Impact factor: 4.200

Review 4.  Modeling kinetics of subcellular disposition of chemicals.

Authors:  Stefan Balaz
Journal:  Chem Rev       Date:  2009-05       Impact factor: 60.622

5.  Four cation-selective transporters contribute to apical uptake and accumulation of metformin in Caco-2 cell monolayers.

Authors:  Tianxiang Kevin Han; William R Proctor; Chester L Costales; Hao Cai; Ruth S Everett; Dhiren R Thakker
Journal:  J Pharmacol Exp Ther       Date:  2015-01-06       Impact factor: 4.030

6.  Drug discovery and regulatory considerations for improving in silico and in vitro predictions that use Caco-2 as a surrogate for human intestinal permeability measurements.

Authors:  Caroline A Larregieu; Leslie Z Benet
Journal:  AAPS J       Date:  2013-01-24       Impact factor: 4.009

Review 7.  Claudins and the modulation of tight junction permeability.

Authors:  Dorothee Günzel; Alan S L Yu
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

8.  Consideration of Fractional Distribution Parameter fd in the Chen and Gross Method for Tissue-to-Plasma Partition Coefficients: Comparison of Several Methods.

Authors:  Yoo-Seong Jeong; William J Jusko
Journal:  Pharm Res       Date:  2022-03-14       Impact factor: 4.580

9.  Protective Effects of Bifidobacterium on Intestinal Barrier Function in LPS-Induced Enterocyte Barrier Injury of Caco-2 Monolayers and in a Rat NEC Model.

Authors:  Xiang Ling; Peng Linglong; Du Weixia; Wei Hong
Journal:  PLoS One       Date:  2016-08-23       Impact factor: 3.240

10.  Butyrate-producing bacteria supplemented in vitro to Crohn's disease patient microbiota increased butyrate production and enhanced intestinal epithelial barrier integrity.

Authors:  Annelies Geirnaert; Marta Calatayud; Charlotte Grootaert; Debby Laukens; Sarah Devriese; Guy Smagghe; Martine De Vos; Nico Boon; Tom Van de Wiele
Journal:  Sci Rep       Date:  2017-09-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.